Swift Medical, a pioneer in digital wound care, has unveiled the new Skin & Wound 2 platform. As the gold standard for the digital wound care segment which it helped to create, Swift's award-winning platform has been used for over 50 million patient assessments in home health, ambulatory, acute, and skilled nursing settings. With over 22 peer-reviewed publications, the company has stayed true to its commitment to clinically validate its groundbreaking innovations and has proven outcomes in accuracy, equitable AI and improved healing rates.

“Skin & Wound 2 demonstrates our continued commitment to empowering clinicians with the most advanced tools available, enabling the delivery of superior wound care outcomes,” said Dwayne Sansone, CEO of Swift Medical. “For nearly a decade, Swift Medical has been committed to delivering an inclusive, unbiased approach to digital wound care. We see it as our moral responsibility to harness the power of generative AI to revolutionize patient diagnostics, ensuring highly accurate results for every skin tone. Our mission is to Heal Our World Faster by leveraging AI to ensure that every patient, regardless of their background, receives the most precise and equitable care possible."

For the full press release, click here.